ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2400

In Rheumatoid Arthritis: Vitamin-D Deficiency Is an Outcome and a Cause of Subclinical Renal Impairment

Suad Hannawi1 and Issa Al Salmi2, 1Rheumatology, Asst.Prof, Dubai, United Arab Emirates, 2Prof, Muscat, Oman

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: inflammation and rheumatoid arthritis (RA), Kidney, Vitamin D

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Vitamin D deficiency is highly prevalent in patients with rheumatoid arthritis (RA), and it is linked to RA disease severity. Two steps of hydroxylation are required to activate vitamin-D, the first is carried out in the liver to be converted to 25-vitamin-D and then in the kidney to 1,25 vitamin-D; the active form. Subclinical kidney dysfunction is common in rheumatoid arthritis and might interfere with vitamin-D hydroxylation. This study investigates the relationship between vitamin-D level and kidney function in RA

Methods:

Patient diagnosed by ACR 1988 criteria for RA. 25-viamin D level was obtained. Estimated glomerular filtration rate (eGFR) calculated with Modification of Diet in Renal Disease (MDRD) formula. Univariate regression analysis was carried out to determine the relationship between 25-vitamin-D level and eGFR, other renal parameters, and the inflammatory markers

Results:

55 rheumatoid arthritis patients were included for the study. The mean age was 45 ± 15 year for female and 46 ± 21 year for male. The mean 25-vitamin-D level was 39 ± 28 nmol/l (normal range: 50-80). Mean eGFR was 130 ±25 ml/min/m2..

Univariate linear regression revealed a positive linear relationship between 25-vitamin-D level and weight of the patients (p=0.03, CI: 0.06, 1.04), body surface area (p=0.02, CI: 11-119), body mass index (BMI) (p=0.009, CI: 0.60, 4.00), and calcium level (p=0.02, CI: 7.25, 130). 25-vitamin-D level was negatively associated with eGFR (p=0.040, CI: -0.20, -0.01), microalbuminuria level (p=0.040, CI: -0.63, -0.01), CRP level (P=0.01, CI: -1.16, -0.16) and neutrophil count (p=p=0.03, CI: -1.67, -0.010).

Conclusion:

The negative linear relationship between 25-vitamin D level and the eGFR indicates high level of 25-vitamin-D due to kidney inefficiency in converting 25-vitamin-D to an active form; 1, 25 vitamin-D. Extrarenal activation of vitamin D require a high level of 25-vitamin-D of more than 78 nmol/l (30 ng/ml) for sufficient activation. Vitamin-D receptors are present in most cells in the body and in the T and B lymphocytes. The active form of vitamin-D (1, 25 vitamin-D) is one of the most potent modulator of the immune system. Hence, the negative relationship between 25-vitamin-D and CRP indicate 25-vitamin-D deficiency role in exacerbation of the inflammatory status, and possibly in a further renal function deterioration. Screening for 25-vitamin-D deficiency might be an important step to detect subclinical renal insufficiency. Vitamin-D supplement might help in ameliorating the inflammation of rheumatoid arthritis.


Disclosure: S. Hannawi, None; I. Al Salmi, None.

To cite this abstract in AMA style:

Hannawi S, Al Salmi I. In Rheumatoid Arthritis: Vitamin-D Deficiency Is an Outcome and a Cause of Subclinical Renal Impairment [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/in-rheumatoid-arthritis-vitamin-d-deficiency-is-an-outcome-and-a-cause-of-subclinical-renal-impairment/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-rheumatoid-arthritis-vitamin-d-deficiency-is-an-outcome-and-a-cause-of-subclinical-renal-impairment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology